Katsuyama, Japan

Noriyuki Yagi

This inventor holds 2 USPTO granted patents. Top assignee: Hokuriku Pharmaceutical Co., Ltd.. Active years: 1985-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriyuki Yagi. Retrieved from https://idiyas.com/inventor/noriyuki-yagi-6b07na39

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 19(Granted Patents)


Location History:

  • Katsuyamashi, JP (1985)
  • Katsuyama, JP (1992)

Company Filing History:


Years Active: 1985-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Noriyuki Yagi: Contributions to Pharmaceutical Chemistry

Introduction

Noriyuki Yagi, an accomplished inventor based in Katsuyama, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a total of two patents to his name, Yagi has focused on developing compounds that address infectious diseases and provide therapeutic solutions.

Latest Patents

Yagi's latest innovations include two notable patents. The first is centered around thiazetoquinoline-3-carboxylic acid derivatives. This invention encompasses a compound represented by the general formula (I), where R₁ can be a hydrogen atom or a lower alkyl group, R₂ can be a fluorine atom or a chlorine atom, R₃ can be various groups such as hydrogen, lower alkyloyl, or halogenated lower alkanoyl, and R₄ can also be a hydrogen atom or a lower alkyl group. This patent outlines a process for preparing these derivatives, a pharmaceutical composition that includes them, and methods for treating infectious diseases using these compounds.

The second patent focuses on 6-fluoro-1, 4-dihydro-4-oxo-7-substituted piperazinylquinoline-3-carboxylic acids, represented by another formula (I). This invention also provides a pharmacologically acceptable salt of the compound and details the process for preparation. It emphasizes the creation of a pharmaceutical composition containing these new compounds as active ingredients, with potential therapeutic applications against bacterial infections.

Career Highlights

Yagi is affiliated with Hokuriku Pharmaceutical Co., Ltd., a company committed to advancing pharmaceutical innovations. Throughout his career, his research has significantly impacted the development of new medications aimed at combating infectious diseases.

Collaborations

During his journey, Noriyuki Yagi has collaborated with notable colleagues, including Hideo Kato and Nobuo Ogawa. Together, they have fostered a collaborative research environment that promotes the development of pioneering pharmaceutical solutions.

Conclusion

Noriyuki Yagi’s contributions to the field of pharmaceutical chemistry are encapsulated in his innovative patents. His work continues to inspire advancements in treating infectious diseases and showcases the vital role of inventors in the medical landscape. Through his endeavors, Yagi reinforces the importance of innovation in addressing global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…